9/3/2024

Pantoprazole Injection

Products Affected - Description

- Pantoprazole lyophilized powder for injection, Hikma, 40 mg, vial, 10 count, NDC 00143-9284-10
- Pantoprazole lyophilized powder for injection, Sandoz, 40 mg, vial, 10 count, NDC 00781-3232-95

Reason for the Shortage

- Eugia (AuroMedics) has pantoprazole injection available.
- Fresenius Kabi has pantoprazole injection available.
- Hikma has pantoprazole injection on shortage due to increased demand.
- Meitheal has pantoprazole injection available.
- Pfizer has Protonix available.
- Piramal has pantoprazole injection available.
- Sagent has pantoprazole injection available.
- Sandoz did not provide a reason for the shortage.
- Sun Pharma has pantoprazole injection available.

Available Products

- Protonix IV, Pfizer, 40 mg, vial, 10 count, NDC 00008-0923-55
- Protonix IV, Pfizer, 40 mg, vial, 25 count, NDC 00008-0923-60
- Pantoprazole lyophilized powder for solution for injection, Eugia US, 40 mg, vial, 10 count, NDC 55150-0202-10
- Pantoprazole lyophilized powder for injection, Fresenius Kabi, 40 mg, vial, 10 count, NDC 65219-0433-15
- Pantoprazole lyophilized powder for injection, Meitheal Pharmaceuticals, 40 mg, vial, 10 count, NDC 71288-0600-11
- Pantoprazole lyophilized powder for injection, Piramal Critical Care, 40 mg, vial, 10 count, NDC 66794-0258-41
- Pantoprazole lyophilized powder for injection, Sagent, 40 mg, vial, 10 count, NDC 25021-0751-10
- Pantoprazole lyophilized powder for injection, Sagent, 40 mg, vial, 25 count, NDC 25021-0751-11
- Pantoprazole powder for solution for injection, Sun Pharma, 40 mg, vial, 10 count, NDC 70095-0024-02
- Pantoprazole powder for solution for injection, Sun Pharma, 40 mg, vial, 25 count, NDC 70095-0024-03

Estimated Resupply Dates

- Hikma has pantoprazole 40 mg vials on allocation.
- Sandoz has pantoprazole 40 mg vials available in limited supply.

Updated

Updated September 3, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 28, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.